Larry Yun Fang, Age 67Langhorne, PA

Larry Fang Phones & Addresses

Langhorne, PA

Plainsboro, NJ

Brooklyn, NY

Englewood, NJ

Mentions for Larry Yun Fang

Larry Fang resumes & CV records

Resumes

Larry Fang Photo 21

Senior Principal Scientist

Location:
New York, NY
Industry:
Pharmaceuticals
Work:
Schering-Plough Research Institute
Senior Principal Scientist
Education:
The Graduate Center, City University of New York 1987 - 1992
Schering - Plough Research Institute
Larry Fang Photo 22

Pharmaceutical

Location:
New York, NY
Industry:
Oil & Energy
Work:
Mer 7
pharmaceutical
Larry Fang Photo 23

Larry Fang

Publications & IP owners

Us Patents

Pharmaceutical Compositions

US Patent:
2005015, Jul 14, 2005
Filed:
Dec 16, 2004
Appl. No.:
11/013676
Inventors:
Larry Fang - Plainsboro NJ, US
Prudence Bradley - Cranford NJ, US
Ping Lee - Toronto, CA
International Classification:
A61K031/496
US Classification:
514253110
Abstract:
Disclosed herein are novel compositions useful for the treatment of androgen dependant diseases.

Pharmaceutical Compositions

US Patent:
2009011, Apr 30, 2009
Filed:
Dec 9, 2008
Appl. No.:
12/331015
Inventors:
Larry Yun Fang - Plainsboro NJ, US
Prudence K. Bradley - Cranford NJ, US
Ping L. Lee - Radnor NJ, US
International Classification:
A61K 31/496
A61P 5/26
US Classification:
51425313
Abstract:
Disclosed herein are novel compositions useful for the treatment of androgen dependant diseases.

Oral Pharmaceutical Compositions In A Solid Dispersion Comprising Preferably Posaconazole And Hpmcas

US Patent:
2011003, Feb 10, 2011
Filed:
Apr 15, 2009
Appl. No.:
12/937881
Inventors:
Larry Yun Fang - Plainsboro NJ, US
Jiansheng Wan - Warren NJ, US
David Harris - New Providence NJ, US
International Classification:
A61K 31/496
A61P 31/10
US Classification:
51425407
Abstract:
The present invention provides a solid molecularly dispersed composition comprising a poorly water soluble and weakly basic azole antifungal compound and a pH sensitive polymer, pharmaceutical compositions, comprising the solid molecularly dispersed composition of the invention and methods of treating and/or preventing a fungal infection in a patient in need thereof comprising orally administering a pharmaceutical composition comprising a composition of the invention to a patient in need thereof. Preferably the antifungal, compound is posaconazole, and the pH sensitive polymer is HPMCAS.

High Density Compositions Containing Posaconazole And Formulations Comprising The Same

US Patent:
2011012, May 26, 2011
Filed:
Apr 15, 2009
Appl. No.:
12/999547
Inventors:
Larry Yun Fang - Plainsboro NJ, US
David Harris - New Providence NJ, US
Gopal Krishna - North Brunswick NJ, US
Russell C. Prestipino - Hoboken NJ, US
Marc Steinman - Livingston NJ, US
Jiansheng Wan - Warren NJ, US
Hetty Anne Waskin - Skillman NJ, US
International Classification:
A61K 31/496
A61K 9/14
A61P 31/10
US Classification:
424489, 51425407
Abstract:
The present application provides novel compositions comprising posaconazole and a polymer wherein the composition has a glass transition temperature (Tg) of less than about 1100 C. The application also describes compositions comprising posaconazole and a polymer having a bulk density of greater than about 0.4 mg/mL. The application also describes compositions comprising posaconazole and a polymer which provide an exposure (AUCtf) of at least about 10,000 nghr/mL when administered to a patient in a fasted state. The application also describes a novel process for preparing these compositions. The preff erred polymer is HPMCAS. Preferably the composition is an extruded material.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.